Related Experiment Video
Updated: Jun 2, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Clinical Outcomes in a Multicenter Cohort Involving 919 Patients With Hypertriglyceridemia-Associated Acute
Hanzhang Deng1,2,3, Kaixin Peng1,2,3, Liang Zhang2
1Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) increases the risk of severe acute pancreatitis (AP) and organ failure. A validated prediction model identifies key risk factors for severe HTG-AP, aiding early intervention.
Area of Science:
- Gastroenterology
- Internal Medicine
- Critical Care Medicine
Background:
- Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) is a common cause of acute pancreatitis (AP) globally.
- Previous studies on the severity of HTG-AP compared to other etiologies have yielded inconsistent results due to confounding factors.
Purpose of the Study:
- To investigate the risk and risk factors associated with developing severe AP in patients with HTG-AP.
- To develop and validate a predictive model for severe AP in the context of HTG-AP.
Main Methods:
- A multicenter cohort study included 4,378 patients with AP from January 2013 to December 2023.
- Multivariable logistic regression was used to identify risk factors for severe AP after adjusting for confounders.
- A prediction model was developed and validated using training and testing datasets.
Main Results:
- HTG-AP patients exhibited a significantly higher risk of severe AP (OR: 1.897) and organ failure compared to other AP etiologies.
- Key risk factors for severe AP in HTG-AP patients included advanced age, elevated fasting blood glucose, high white blood cell counts, and pleural effusion.
- The developed prediction model showed strong performance with an AUC of 0.837 (training) and 0.883 (testing).
Conclusions:
- HTG-AP is associated with an increased risk of severe AP and organ failure.
- A validated risk prediction model effectively stratifies patients for severe HTG-AP, enabling targeted management.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

